{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:43:48Z","timestamp":1784778228915,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Biogen, Inc"},{"DOI":"10.13039\/100000894","name":"SMA Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000894","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007721","name":"Cure SMA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007721","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ionic Pharmaceuticals"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12883-017-0853-y","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T02:43:31Z","timestamp":1491360211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["A qualitative study of perceptions of meaningful change in spinal muscular atrophy"],"prefix":"10.1186","volume":"17","author":[{"given":"Sarah","family":"McGraw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Henne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Jarecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Hobby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Shi","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,4]]},"reference":[{"key":"853_CR1","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/ajmg.a.33474","volume":"152","author":"TW Prior","year":"2010","unstructured":"Prior TW, Snyder PJ, Rink BD, Pearl DK, Pyatt RE, Mihal DC, et al. Newborn and carrier screening for spinal muscular atrophy. Am J Med Genet Part A. 2010;152:1608\u201316. doi: 10.1002\/ajmg.a.33474 .","journal-title":"Am J Med Genet Part A"},{"key":"853_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2011.134","volume":"20","author":"EA Sugarman","year":"2012","unstructured":"Sugarman EA, Nagan N, Zhu H, Akmaev VR, Zhou Z, Rohlfs EM, et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72\u2009400 specimens. Eur J Hum Genet. 2012;20:27\u201332. doi: 10.1038\/ejhg.2011.134 .","journal-title":"Eur J Hum Genet"},{"key":"853_CR3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/jmg.15.6.409","volume":"15","author":"J Pearn","year":"1978","unstructured":"Pearn J. Incidence, prevalence, and gene frequency studies of chronic childhood muscular atrophy. J Med Genet. 1978;15:409\u201313.","journal-title":"J Med Genet"},{"key":"853_CR4","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/sj.ejhg.5201288","volume":"12","author":"S Ogino","year":"2004","unstructured":"Ogino S, Wilson RB, Gold B. New insights on the evolution of the SMN1 and SMN2 region: simulation and meta-analysis for allele and haplotype frequency calculations. Eur J Hum Genet. 2004;12:1015\u201323. doi: 10.1038\/sj.ejhg.5201288 .","journal-title":"Eur J Hum Genet"},{"key":"853_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mus.24497","volume":"51","author":"WD Arnold","year":"2015","unstructured":"Arnold WD, Kassar D, Kissel JT. Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle Nerve. 2015;51:157\u201367. doi: 10.1002\/mus.24497 .","journal-title":"Muscle Nerve"},{"key":"853_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1750-1172-8-44","volume":"8","author":"N Kayadjanian","year":"2013","unstructured":"Kayadjanian N, Burghes A, Finkel RS, Mercuri E, Rouault F, Schwersenz I, et al. SMA-EUROPE workshop report: opportunities and challenges in developing clinical trials for spinal muscular atrophy in Europe. Orphanet J Rare Dis. 2013;8:44. doi: 10.1186\/1750-1172-8-44 .","journal-title":"Orphanet J Rare Dis"},{"key":"853_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/0883073807305788","volume":"22","author":"CH Wang","year":"2007","unstructured":"Wang CH, Finkel RS, Bertini ES, Schroth M, Simonds A, Wong B, et al. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. 2007;22:1027\u201349. doi: 10.1177\/0883073807305788 .","journal-title":"J Child Neurol"},{"key":"853_CR8","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/archneurol.2010.373","volume":"68","author":"P Kaufmann","year":"2011","unstructured":"Kaufmann P, McDermott MP, Darras BT, Finkel R, Kang P, Oskoui M, et al. Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Arch Neurol. 2011;68:779\u201386. doi: 10.1001\/archneurol.2010.373 .","journal-title":"Arch Neurol"},{"key":"853_CR9","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1177\/0883073807305672.Spinal","volume":"22","author":"C Meldrum","year":"2007","unstructured":"Meldrum C, Scott C, Swoboda KJ. Spinal muscular atrophy genetic counseling access and genetic knowledge: parents\u2019 perspectives. J Child Neurol. 2007;22:1019\u201326. doi: 10.1177\/0883073807305672.Spinal .","journal-title":"J Child Neurol"},{"key":"853_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2011.09.001","volume":"46","author":"J Markowitz","year":"2012","unstructured":"Markowitz J. A., Singh P, Darras BT. Spinal muscular atrophy: a clinical and research update. Pediatr Neurol. 2012;46:1\u201312. doi: 10.1016\/j.pediatrneurol.2011.09.001 .","journal-title":"Pediatr Neurol"},{"key":"853_CR11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/ahg.12031","volume":"77","author":"DK Nurputra","year":"2013","unstructured":"Nurputra DK, Lai PS, Harahap NIF, Morikawa S, Yamamoto T, Nishimura N, et al. Spinal muscular atrophy: from gene discovery to clinical trials. Ann Hum Genet. 2013;77:435\u201363. doi: 10.1111\/ahg.12031 .","journal-title":"Ann Hum Genet"},{"key":"853_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.clinthera.2013.11.006","volume":"36","author":"C Zanetta","year":"2014","unstructured":"Zanetta C, Nizzardo M, Simone C, Monguzzi E, Bresolin N, Comi GP, et al. Molecular therapeutic strategies for spinal muscular atrophies: current and future clinical trials. Clin Ther. 2014;36:128\u201340. doi: 10.1016\/j.clinthera.2013.11.006 .","journal-title":"Clin Ther"},{"key":"853_CR13","doi-asserted-by":"publisher","unstructured":"Waldman R, Bosboom W, van den Berg L, Wokke J, Iannaccone S, Vrancken A. Drug treatment for spinal muscular atrophy types II and III. Cochrane Database Syst Rev. 2011;(4):CD006282. doi: 10.1002\/14651858.CD006282.pub4 .","DOI":"10.1002\/14651858.CD006282.pub4"},{"key":"853_CR14","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1212\/WNL.0b013e318271f7e4","volume":"79","author":"P Kaufmann","year":"2012","unstructured":"Kaufmann P, McDermott MP, Darras BT, Finkel RS, Sproule DM, Kang PB, et al. Prospective cohort study of spinal muscular atrophy types 2 and 3. Neurology. 2012;79:1889\u201397. doi: 10.1212\/WNL.0b013e318271f7e4 .","journal-title":"Neurology"},{"key":"853_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.nmd.2013.10.011","volume":"24","author":"J Kirschner","year":"2014","unstructured":"Kirschner J, Schorling D, Hauschke D, Rensing-Zimmermann C, Wein U, Grieben U, et al. Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot study. Neuromuscul Disord. 2014;24:134\u201342. doi: 10.1016\/j.nmd.2013.10.011 .","journal-title":"Neuromuscul Disord"},{"key":"853_CR16","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1212\/WNL.0b013e3182020332","volume":"75","author":"T Chen","year":"2010","unstructured":"Chen T. Randomized, double-blind, placebo-controlled trial of Hydroxyurea in spinal muscular atrophy. Neurology. 2010;75:2190\u20137.","journal-title":"Neurology"},{"key":"853_CR17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1090-3798(03)00060-6","volume":"7","author":"E Mercuri","year":"2003","unstructured":"Mercuri E, Bertini E, Muntoni F. The Hammersmith motor functional scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. Eur J Paediatr Neurol. 2003;7:155\u20139.","journal-title":"Eur J Paediatr Neurol"},{"key":"853_CR18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.nmd.2007.05.009","volume":"17","author":"J O\u2019Hagen","year":"2007","unstructured":"O\u2019Hagen J, Glanzman AM, M.P. M. An expanded version of the Hammersmith functional motor scale for SMA II and III patients. Neuromuscul Disord. 2007;17:693\u20137.","journal-title":"Neuromuscul Disord"},{"key":"853_CR19","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1177\/0883073811420294","volume":"26","author":"AM Glanzman","year":"2011","unstructured":"Glanzman AM, JM O\u2019H, MP MD, Martens WB. Validation of the expanded Hammersmith functional motor scale in spinal muscular atrophy type II and III. J Child Neurol. 2011;26:1499\u2013507.","journal-title":"J Child Neurol"},{"issue":"6","key":"853_CR20","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/mus.24670","volume":"52","author":"J Montes","year":"2015","unstructured":"Montes J, Glanzman AM, Mazzone ES, Martens WB, Dunaway S, Pasternak A, et al. SMA functional composite score: a functional measure in spinal muscular atrophy. Muscle and Nerve. 2015;52(6):942\u20137.","journal-title":"Muscle and Nerve"},{"key":"853_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.nmd.2014.11.008","volume":"25","author":"S Sivo","year":"2015","unstructured":"Sivo S, Mazzone E, Antonaci L, De Sanctis R, Fanelli L, Palermo C, et al. Upper limb module in non-ambulant patients with spinal muscular atrophy: 12 month changes. Neuromuscul Disord. 2015;25:212\u20135. doi: 10.1016\/j.nmd.2014.11.008 .","journal-title":"Neuromuscul Disord"},{"key":"853_CR22","doi-asserted-by":"publisher","unstructured":"Seferian AM, Moraux A, Canal A, Decostre V, Diebate O, Le Moing AG, et al. Upper Limb Evaluation and One-Year Follow Up of Non-Ambulant Patients with Spinal Muscular Atrophy: An Observational Multicenter Trial. PLoS One 2015;10. doi: 10.1371\/journal.pone.0121799 .","DOI":"10.1371\/journal.pone.0121799"},{"key":"853_CR23","doi-asserted-by":"publisher","unstructured":"Mazzone E, Bianco F, Martinelli D, Glanzman AM, Messina S, Sanctis R De, et al. Assessing upper limb function in nonambulant SMA patients: development of a new module. Neuromuscul Disord 2011;21:406\u2013412. doi: 10.1016\/j.nmd.2011.02.014 .","DOI":"10.1016\/j.nmd.2011.02.014"},{"key":"853_CR24","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.clinthera.2014.04.011","volume":"36","author":"H Peay","year":"2014","unstructured":"Peay H, Hollin I, Fischer R, Bridges JFP. A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for duchenne muscular distrophy. Clin Ther. 2014;36:624\u201337.","journal-title":"Clin Ther"},{"key":"853_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0895-4356(03)00044-1","volume":"56","author":"RD Crosby","year":"2003","unstructured":"Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003;56:395\u2013407. doi: 10.1016\/S0895-4356(03)00044-1 .","journal-title":"J Clin Epidemiol"},{"key":"853_CR26","unstructured":"FDA HHS. Guidance for industry use in medical product development to support labeling claims guidance for industry. Clin Fed Regist. 2009:1\u201339."},{"key":"853_CR27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1586\/erp.11.12","volume":"11","author":"LD McLeod","year":"2011","unstructured":"McLeod LD, Coon CD, Martin SA, Fehnel SE, Hays RD. Interpreting patient-reported outcome results: US FDA guidance and emerging methods. Expert Rev Pharmacoecon Outcomes Res. 2011;11:163\u20139.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"853_CR28","unstructured":"Qian Y, McGraw S, Henne J, Jarecki J, Hobby K, Yeh W. Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study n.d."},{"key":"853_CR29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1090-3798(03)00060-6","volume":"7","author":"M Main","year":"2003","unstructured":"Main M. The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. Eur J Paediatr Neurol. 2003;7:155\u20139.","journal-title":"Eur J Paediatr Neurol"},{"key":"853_CR30","volume-title":"The discovery of grounded theory: strategies for qualitative research","author":"B Glaser","year":"1967","unstructured":"Glaser B, Strauss A. The discovery of grounded theory: strategies for qualitative research. Chicago: Aldine Publishing Company; 1967."},{"key":"853_CR31","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1475-6773.2006.00684.x","volume":"42","author":"EH Bradley","year":"2007","unstructured":"Bradley EH, Curry LA, Devers KJ. Qualitative data analysis for health services research: developing taxonomy, themes, and theory. J Heal Serv Res. 2007;42:1758\u201372.","journal-title":"J Heal Serv Res"},{"key":"853_CR32","unstructured":"Dedoose: 6.1.11 n.d. dedoose.com . Accessed 2 Apr 2017."},{"key":"853_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12883-017-0790-9","volume":"17","author":"MC Pera","year":"2017","unstructured":"Pera MC, Coratti G, Forcina N, Mazzone ES, Scoto M, Montes J, et al. Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy. BMC Neurol. 2017;17:39. doi: 10.1186\/s12883-017-0790-9 .","journal-title":"BMC Neurol"},{"key":"853_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.01.018","author":"F Rouault","year":"2017","unstructured":"Rouault F, Christie-Brown V, Broekgaarden R, Gusset N, Henderson D, Marczuk P, et al. Disease impact on general well-being and therapeutic expectations of European type II and type III spinal muscular atrophy patients. Neuromuscul Disord. 2017; doi: 10.1016\/j.nmd.2017.01.018 .","journal-title":"Neuromuscul Disord"},{"key":"853_CR35","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.nmd.2009.09.009","volume":"19","author":"ST Iannaccone","year":"2009","unstructured":"Iannaccone ST, Hynan LS, Morton A, Buchanan R, Limbers CA, Varni JW. The PedsQL in pediatric patients with spinal muscular atrophy: feasibility, reliability, and validity of the pediatric quality of life inventory generic Core scales and neuromuscular module. Neuromuscul Disord. 2009;19:805\u201312. doi: 10.1016\/j.nmd.2009.09.009 .","journal-title":"Neuromuscul Disord"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-017-0853-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T12:28:24Z","timestamp":1568982504000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-017-0853-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,4]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["853"],"URL":"https:\/\/doi.org\/10.1186\/s12883-017-0853-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,4]]},"article-number":"68"}}